tiprankstipranks
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
AARD
Aardvark Therapeutics, Inc.
RESEARCH TOOLSreports

Aardvark Therapeutics, Inc. (AARD) Stock News & Sentiment

156 Followers
Options Volatility and Implied Earnings Moves Today, April 06, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, April 06, 2026
3d ago
AARD
AIRS
Options Volatility and Implied Earnings Moves This Week, April 06 – April 10, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, April 06 – April 10, 2026
3d ago
BB
BLK
AARD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AARD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
AARD
Aardvark Therapeutics Establishes $150 Million Equity Program
Premium
Company Announcements
Aardvark Therapeutics Establishes $150 Million Equity Program
16d ago
8K
AARD
Balancing Safety Concerns and Long-Term Opportunity: Justifying a Buy Rating on Aardvark Amid ARD-101 Clinical Risks
Premium
Ratings
Balancing Safety Concerns and Long-Term Opportunity: Justifying a Buy Rating on Aardvark Amid ARD-101 Clinical Risks
16d ago
AARD
Aardvark’s ARD-101 Prader-Willi Study Suspended: What Investors Should Watch Next
Premium
Company Announcements
Aardvark’s ARD-101 Prader-Willi Study Suspended: What Investors Should Watch Next
20d ago
AARD
Aardvark’s HERO Extension Trial Paused: What ARD-101’s Status Means for Investors
Premium
Company Announcements
Aardvark’s HERO Extension Trial Paused: What ARD-101’s Status Means for Investors
20d ago
AARD
More AARD News >

AARD News on the Web

Options Volatility and Implied Earnings Moves Today, April 06, 2026
TipRanks News
Neutral
Options Volatility and Implied Earnings Moves This Week, April 06 – April 10, 2026
TipRanks News
Neutral
AARD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Bearish
Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Aardvark Therapeutics, Inc. (AARD) and Incyte (INCY)
TipRanks News
Bullish
Aardvark Therapeutics price target lowered to $8 from $32 at B. Riley
TipRanks News
Bearish
RBC Capital Sticks to Its Hold Rating for Aardvark Therapeutics, Inc. (AARD)
TipRanks News
Neutral
Aardvark Therapeutics Establishes $150 Million Equity Program
TipRanks News
Neutral
Balancing Safety Concerns and Long-Term Opportunity: Justifying a Buy Rating on Aardvark Amid ARD-101 Clinical Risks
TipRanks News
Bullish

News Score - Last 7 Days

Negative
AARD
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.75 articles
News Sentiment
This Week0%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AARD’s Media Buzz Sentiment?
3 articles about AARD were published this week. In an average week, 3.75 articles are published.
    What is AARD’s weekly average amount of articles?
    In an average week, 3.75 articles about AARD are published.
      What is AARD’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      NBIXNeurocrine
      AORTArtivion
      HUMHumana
      ORGOOrganogenesis Holdings
      UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
      Showing the stocks with the most bullish news sentiment over the past week